[HTML] from nih.govM Lukasova, C Malaval, A Gille, J Kero… - The Journal of …, 2011 - ncbi.nlm.nih.gov Nicotinic acid (niacin) is a drug used to reduce the progression of atherosclerosis. Its antiatherosclerotic activity is believed to result from lipid-modifying effects, including its ability to decrease LDL cholesterol and increase HDL cholesterol levels in plasma. Here, we report that in a mouse model of ... Cited by 5 - Related articles - All 4 versions
GJS Pereira, H Hirata, GM Fimia… - Journal of Biological …, 2011 - ASBMB NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE (NAADP) REGULATES AUTOPHAGY IN CULTURED ASTROCYTES ... Gustavo JS Pereira1, Hanako Hirata1, Gian M. Fimia2, Lúcia G. do Carmo1, Claudia Bincoletto1, Sang W. Han3, Roberta S. Stilhano3, Rodrigo Portes ... Related articles - All 2 versions
G Li, X Deng, C Wu, Q Zhou, L Chen, Y Shi… - Journal of Biological …, 2011 - ASBMB Nicotinic acid (niacin) has been widely used as a lipid-lowering drug for several decades, and recently, orphan G protein-coupled receptor GPR109A has been identified as a receptor for niacin. Mechanistic investigations have shown that, upon niacin activation, GPR109A ...
[HTML] from plos.orgY Bermudez, CA Benavente, RG Meyer, WR Coyle… - PloS one, 2011 - dx.plos.org Nicotinic acid increases epidermal differentiation in photodamaged human skin as judged by the terminal differentiation markers caspase 14 and filaggrin. Both GPR109A and GPR109B genes are transcribed in human skin and in epidermal keratinocytes, but expression in ... Related articles - Cached - All 4 versions